(1-Methyl-1,4,5,6-tetrahydro-2-pyrimidinyl)methyl cyclohexyl(hydroxy)phenylacetate hydrochloride (1:1)(CAS: 125-52-0)

This compound is subject to GHS classification for transport and workplace safety. It falls under the REACH regulations in the EU, requiring registration and authorization for substances above a certain tonnage threshold. In the USA, the FDA may regulate it for pharmaceutical applications, and the EPA may have requirements for environmental protection. Proper handling, storage, and disposal must comply with local and international regulations.

There are several alternatives in synthesis, such as using different starting materials or intermediates. Common substitutes include various pyrimidine derivatives and their analogs. For instance, 1-methyl-1,4-dihydro-2H-pyrimidin-2-yl derivatives can serve as alternatives. Isomers and structural analogs can also be explored depending on the specific application.

The market for this compound is growing due to its applications in pharmaceuticals and agrochemicals. Research is focusing on its use as an intermediate in drug synthesis and as a potential therapeutic agent. Price trends are stable, and demand is expected to increase with emerging applications in biotechnology and personalized medicine.

Waste containing this compound should be collected and disposed of according to local regulations. It is recommended to neutralize the waste with an appropriate base before incineration or professional waste disposal. Environmental protection precautions include ensuring that the waste is not released into the environment and that proper personal protective equipment is used during handling.